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The surgical approach to bleeding visceral artery aneurysms has
a mortality rate of 16-50% that is dependent primarily on an-
atomic location and underlying cause. Nineteen patients were
studied over a 10-year period who were definitively treated by
embolization. There was a 79% success rate and no mortality.
The cause of the aneurysms was pancreatitis in 13 patients,
trauma in four patients, subacute bacterial endocarditis in one
patient, and secondary to biliary tract surgery in one patient.
TnHE SURGICAL APPROACH TO bleeding visceral ar-
tery aneurysms has a reported mortality rate of
12-50%, depending primarily on anatomic lo-
cation and underlying cause.'" Stimulated by a patient
with a potential life-threatening gastrointestinal hemor-
rhage who was managed successfully by transcatheter vis-
ceral artery embolization, we reviewed the experience with
embolization at North Carolina Memorial Hospital
(NCMH). We present a representative case report, a de-
scription of the issues involved in embolization proce-
dures, and a review of our 10-year experience with peri-
pancreatic visceral artery aneurysms in 19 patients. The
manifestations of this potentially lethal problem are dis-
cussed.
Case Report
A 67-year-old male with a history of alcohol abuse was transferred to
NCMH with an epigastric mass and persistent abdominal pain that was
aggravated by eating. The patient was afebrile, nonjaundiced, and had
a normal serum amylase level. The white blood cell count was 13,000/
AL and the hematocrit value was 38%. A dynamic contrast-enhanced
computed tomography (CT) examination ofthe abdomen revealed a 5-
cm, rapidly enhancing mass in the tail of the pancreas. A celiac arterio-
gram showed a 5-cm pseudoaneurysm of the splenic artery (Fig. 1). The
patient had Gelfoam (Upjohn, Kalamazoo, MI) and coil embolization
of the splenic artery (Fig. 2). The night after this procedure the patient
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had left upper quadrant pain, more severe than on admission, with a
temperature of 100 F and a white blood cell count elevation to 21,000/
ML. By the next morning the patient was afebrile with a normal white
blood cell count, and his pain was gone. Repeat celiac and superior
mesenteric arteriography showed total occlusion of the splenic artery
without collateral filling ofthe pseudoaneurysm. The patient was put on
a regular diet 2 days later and was discharged 4 days after the emboli-
zation procedure. The patient has remained asymptomatic in 9 months
of follow-up.
Materials and Results
We have performed definitive peripancreatic visceral
artery embolization on 19 patients over the past 10 years.
A summary of the results are presented in Table 1. The
causes ofthe aneurysms were pancreatitis and pseudocyst
in 68% (13 patients); trauma in 21% (4 patients); bacterial
endocarditis in 5% (1 patient); and secondary to biliary
tract surgery in 5% (1 patient). In this study embolization
of peripancreatic visceral aneurysms was performed with
a 79% success rate (15 of 19 patients) with no mortality.
Success is defined as satisfactory thrombosis ofthe aneu-
rysm without any evidence of recurrence on clinical and,
in some cases, radiologic follow-up. In spite ofinitial suc-
cessful control of gastrointestinal hemorrhage, two ofthe
19 patients died of sepsis related to their underlying dis-
ease. Four patients required ancillary surgery, including
drainage ofpseudocyst and intra-abdominal sepsis. Com-
plications were well tolerated without long-term sequelae,
which included thrombosis of the hepatic artery in two
patients and definite rupture of one pseudoaneurysm
during embolization. There have been no rebleeding ep-
isodes in any of the seventeen surviving patients during
the 10-year period.
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EMBOLIZATION OF VISCERAL PSEUDOANEURYSMS
FIG. 1. Splenic arteriogram demonstrating a 5-cm pseudoaneurysm (ar-
rows) arising from the proximal splenic artery.
Discussion
Pancreatitis with secondary pseudocyst formation is the
most common cause of visceral pseudoaneurysms,5 but
they may also occur in the absence ofa pseudocyst. Pseu-
doaneurysms occur in approximately 10% ofpatients with
chronic pancreatitis.6 Significant bleeding occurs in 2-
10% of patients with pancreatitis.4'7'8 These pseudo-
aneurysms are caused by digestion of adjacent vessels by
elastase and trypsin, which may then bleed into a pseu-
docyst, pancreatic duct, peritoneal cavity, the gastroin-
testinal tract, or the retroperitoneum.7'9 True aneurysms
on the basis of atherosclerosis are known to occur but are
a much less common cause of bleeding.'0 Although any
visceral artery may develop a pseudoaneurysm, the splenic
artery is most commonly affected, followed by the gas-
troduodenal and pancreaticoduodenal arteries.2'7 Since
pancreatitis is the most common underlying cause, the
most common patients will be male alcoholics (80-90%)
with a history ofepisodes ofchronic pancreatitis and sec-
ondary pseudocyst formation.' The diagnosis of visceral
artery aneurysm should be considered in any patient with
a pseudocyst and a significant abdominal bruit. The clin-
ical symptoms are highly variable but very suggestive.
Critical clues are: (1) anemia of unexplained cause, (2)
recurrent and intermittent hematemesis or hematochezia,
(3) rapid enlargement of a previously stable pseudocyst,
and (4) the syndrome known as "hemosuccus pancreat-
icus," characterized by bleeding from the ampulla ofVater
colicky pain, and jaundice. The latter syndrome described
by Sandblom" and others'2-'4 is caused by the passage
ofblood clot through the pancreatic or common bile duct.
Differential diagnosis should include other causes of gas-
trointestinal bleeding in patients with alcoholism, pan-
creatitis, portal hypertension, and pseudocyst. Several di-
agnostic tests are helpful, such as high elevations of the
FIG. 2. Celiac arteriogram after embolization of the splenic artery. Gel-
foam/Pantopaque mixture was used to peripherally embolize the splenic
artery followed by two steel coils to produce permanent occlusion across
the splenic artery segment from which the pseudoaneurysm originated.
serum amylase level, pancreatic calcifications on abdom-
inal radiographs, endoscopy to demonstrate blood clot in
the ampulla of Vater or elsewhere in the upper gastroin-
testinal tract, and ultrasonography or dynamic contrast-
enhanced CT to show the aneurysm. However, the single
most valuable examination to establish the diagnosis is
selective angiography ofthe celiac and superior mesenteric
arteries and their branches, 3 5 15,16
Once the, diagnosis of visceral artery aneurysm with
bleeding is established, therapy should be immediate, since
mortality rates without treatment approaches I00%.2 Even
in the absence of active hemorrhage, in our experience,
pseudoaneurysms secondary to pancreatitis should be
treated as they do not appear to spontaneously thrombose
early.
TABLE 1. Results ofEmbolization
No. of Successful
Visceral Artery Patients Embolization Complications
Pancreaticoduodenal 5 4/5 Occlusion of right
hepatic artery*





Hepatic 2 2/2 Fever, abnormal
LFT's
Left gastric 2 1/2
Total 19 15/19 (79%) 3/19 (16%)
LFT's = liver function tests.
* 2 patients had collateral blood flow, LFT's remained normal.
** Catheter left in place 5 days on Pitressin with no rebleed.
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The recommended traditional surgical approach has
included bipolar arterial ligation, direct intrapseudocyst
ligation, or resection ofthat segment ofthe pancreas with
the pseudocyst and pseudoaneurysm.33'8
These approaches unfortunately have an operative
mortality rate of 16-50%, depending primarily on the an-
atomic location of the pseudoaneurysm rather than the
method of surgery.2'3'7 Thus, surgical intervention for
treatment ofpseudoaneurysm in the head ofthe pancreas
has a 50% mortality rate, but only a 16% mortality rate
in the body or tail of the pancreas.
There are isolated reports in earlier literature ofselective
embolization of visceral artery aneurysms.6'9'7,8 Our own
experience of a 79% success rate and no mortality from
hemorrhage or morbid complications of embolization in
19 patients leads us to conclude that embolization is the
preferred initial treatment in the management of peri-
pancreatic visceral aneurysms. Furthermore, for the ma-
jority of such patients, embolization is the definitive
treatment. Complications of the underlying disease may
still require surgical intervention (e.g., pseudocyst or ab-
scess drainage), but without the attendant risk of surgical
control of the pseudoaneurysm. Embolization may be a
particularly advantageous approach in a patient who
bleeds from a peripancreatic visceral artery aneurysm in
the postoperative period after drainage of a pancreatic
pseudocyst.
Various embolization techniques have been used, but
are essentially decided by the clinical status ofthe patient,
the visceral arterial anatomy, particularly in relation to
the end organ supplied, and the specific geometry of the
aneurysm. Although Gelfoam does not produce perma-
nent arterial occlusion, the aneurysm remains throm-
bosed.9 More permanent arterial occluding materials such
as Ivalon (Unipoint Laboratories, High Point, NC), in-
travascular steel coils,'7 detatchable balloons, electroco-
agulation, or cyanoacrylate glues occasionally may be re-
quired under specific anatomic circumstances to prevent
distal organ infarction. Potential complications of ther-
apeutic embolization are largely related to embolizing
"normal" vessels and are further determined by the spe-
cific anatomy. The liver can tolerate considerable arterial
embolization without significant consequence due to
multiple collateral pathways.'9 The spleen may be em-
bolized to a limited degree in the management of hyper-
splenism.20 On the other hand, the small and large bowel
are at considerable jeopardy from misplaced emboli.
Pseudoaneurysms secondary to pancreatitis may be ex-
tremely fragile and require careful choice ofembolic ma-
terial to avoid rupture during the endovascular procedure.9
Conclusion
Visceral artery pseudoaneurysm should be suspected
in any patient with chronic pancreatitis and unexplained
blood loss. The sine qua non of diagnosis is selective an-
giography. Since the surgical mortality rate is 16-50%,
depending on anatomic location ofthe aneurysm, selective
embolization should be performed in all patients as an
initial method to control bleeding. The results of this re-
port indicate that the majority of patients with pseudo-
aneurysms can be treated definitively by embolotherapy.
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